课题基金 / 基金详情

WEEKLY ONE HOUR PACLITAXEL IN REFRACTORY METASTATIC BREAST CANCER

WEEKLY ONE HOUR PACLITAXEL IN REFRACTORY METASTATIC BREAST CANCER
每周一小时紫杉醇治疗难治性转移性乳腺癌
批准号：
6115811
负责人：
JAMES SPEYER
金额：
$2.1万
依托单位：
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6115811
关键词：
breast neoplasms clinical research drug administration rate /duration human subject human therapy evaluation metastasis neoplasm /cancer chemotherapy paclitaxel

项目摘要

项目成果

JAMES SPEYER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objectives of this Phase II clinical trial are to determine the objective response rate of paclitaxel (Taxol) given as a weekly one hour infusion (80 mg/m2) in patients with previously treated refractory metastatic breast cander; to evaluate the safety of this regimen and to assess overall survival and quality of life in these patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protocol Review and Monitoring
WEEKLY ONE HOUR PACLITAXEL IN REFRACTORY METASTATIC BREAST CANCER
DEXRAZOXANE, DOXORUBICIN & ESCALATING DOSES OF PACLITAXEL IN ADVANCED BREAST CA
WEEKLY ONE HOUR PACLITAXEL IN REFRACTORY METASTATIC BREAST CANCER
海外基金